Kinetic analysis of Enterococcus faecium L,D-transpeptidase inactivation by carbapenems

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3409-3412

  Dubée, Vincent ^a,b,c   Arthur, Michel ^a,b,c   Fief, Hélène ^d,e   Triboulet, Sébastien ^a,b,c   Mainardi, Jean Luc ^a,b,c,f   Gutmann, Laurent ^a,b,c,f   Sollogoub, Matthieu ^d,e   Rice, Louis B ^g   Ethève Quelquejeu, Mélanie ^d,e   Hugonnet, Jean Emmanuel ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Université Pierre et Marie Curie   (France)

^e CNRS   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; CARBAPENEM; DORIPENEM; ERTAPENEM; GAMMA GLUTAMYLTRANSFERASE; IMIPENEM; MEROPENEM; PENICILLIN BINDING PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM MUTANT; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME KINETICS; HYDROLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY;

CARBAPENEMS; ENTEROCOCCUS FAECIUM; ENZYME ACTIVATION; PEPTIDYL TRANSFERASES;

EID: 84861163276     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06398-11     Document Type: Article

References (17)

1. Biarrotte-Sorin S, et al. 2006. Crystal structure of a novel beta-lactaminsensitive peptidoglycan transpeptidase. J. Mol. Biol. 359:533-538. (Pubitemid 43786404)
2. Gupta R, et al. 2010. The Mycobacterium tuberculosis protein Ldt(Mt2) is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. Nat. Med. 16:466-469.
3. Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE III, Blanchard JS. 2009. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science 323:1215-1218.
4. Lavollay M, et al. 2008. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J. Bacteriol. 190:4360-4366. (Pubitemid 351812884)
5. Lavollay M, et al. 2011. The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L,D-transpeptidases. J. Bacteriol. 193:778-782.
6. Magnet S, Dubost L, Marie A, Arthur M, Gutmann L. 2008. Identification of the L,D-transpeptidases for peptidoglycan cross-linking in Escherichia coli. J. Bacteriol. 190:4782- 4785.
7. Mainardi JL, et al. 2005. A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathway. J. Biol. Chem. 280: 38146-38152.
8. Mainardi JL, Hugonnet JE, Gutmann L, Arthur M. 2011. Fighting resistant tuberculosis with old compounds: the carbapenem paradigm. Clin. Microbiol. Infect. 17:1755-1756.
9. Mainardi JL, et al. 2007. Unexpected inhibition of peptidoglycan LD-transpeptidase from Enterococcus faecium by the beta-lactam imipenem. J. Biol. Chem. 282:30414 -30422.
10. Mainardi JL, et al. 2000. Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium. J. Biol. Chem. 275:16490 -16496.
11. Mainardi JL, Villet R, Bugg TD, Mayer C, Arthur M. 2008. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria. FEMS Microbiol. Rev. 32:386-408. (Pubitemid 351257816)
12. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. 2011. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55:4943- 4960.
13. Peltier J, et al. 2011. Clostridium difficile has an original peptidoglycan structure with a high level of N-acetylglucosamine deacetylation and mainly 3-3 cross-links. J. Biol. Chem. 286:29053-29062.
14. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32:234 -258.
15. Tewari N, et al. 2007. An improved procedure for preparation of carbapenem antibiotic: meropenem. Org. Process Res. Dev. 11:773-775.
16. Triboulet S, et al. 2011. Inactivation kinetics of a new target of betalactam antibiotics. J. Biol. Chem. 286:22777-22784.
17. Veziris N, Truffot C, Mainardi JL, Jarlier V. 2011. Activity of carbapenems combined with clavulanate against murine tuberculosis. Antimicrob. Agents Chemother. 55:2597-2600.